Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zivo Bioscience Inc ZIVO

Consumer Defensive Household & Personal Products
Zivo Bioscience, Inc. is a research and development company. The Company operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product... see more

Recent & Breaking News (OTCQB:ZIVO)

ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens

Business Wire August 23, 2024

Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience's Coccidiosis Treatment in Broiler Chickens

Business Wire July 8, 2024

ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study

Business Wire February 7, 2024

ZIVO Bioscience Announces Uplisting to OTCQB Market

Business Wire January 29, 2024

ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Business Wire January 23, 2024

ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Business Wire October 30, 2023

ZIVO Bioscience Announces Reverse Stock Split

Business Wire October 26, 2023

ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference

GlobeNewswire October 3, 2023

Trial Results Confirm Efficacy of ZIVO Bioscience's Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Business Wire September 19, 2023

ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food

Business Wire July 26, 2023

ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market

Business Wire June 30, 2023

ZIVO's GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient

Business Wire May 30, 2023

ZIVO Bioscience Receives $1 Million Bridge Financing

Business Wire April 5, 2023

ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Business Wire February 10, 2023

ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business

Business Wire October 24, 2022

ZIVO Bioscience CEO Issues Letter to Shareholders

Business Wire September 23, 2022

ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment

Business Wire August 10, 2022

Zivo Bioscience Joins Russell Microcap® Index

Business Wire June 27, 2022

Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq

Business Wire April 25, 2022

ZIVO Bioscience Names Chairman John B. Payne as President and CEO

Business Wire January 10, 2022